• 19895 Citations
  • 58 h-Index
1989 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Chronic Hepatitis C Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genotype Medicine & Life Sciences
Interferons Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

Research Output 1989 2018

Parsing the guidelines on guidelines: Balancing sensibility and conflict of interest

Zucker, S. D. & Fried, M. W. Jan 1 2018 (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Conflict of Interest
Guidelines
2 Citations

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Evon, D. M., Amador, J., Stewart, P., Reeve, B. B., Lok, A. S., Sterling, R. K., Di Bisceglie, A. M., Reau, N., Serper, M., Sarkar, S., Lim, J. K., Golin, C. E. & Fried, M. W. Apr 1 2018 In : Alimentary Pharmacology and Therapeutics. 47, 7, p. 1001-1011 11 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Psychometrics
Information Systems
Antiviral Agents
Hepacivirus
1 Citations
Ribavirin
Virus Diseases
Hepacivirus
Fibrosis
Genotype

Controversies in hepatitis C therapy: Reactivation of hepatitis B virus

Lieber, S. R. & Fried, M. W. Oct 1 2017 In : Clinical Liver Disease. 10, 4, p. 87-92 6 p.

Research output: Contribution to journalReview article

Hepatitis C
Hepatitis B virus
Therapeutics
14 Citations

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study

Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., Lim, J. K., Darling, J., Pockros, P., Galati, J. S., Frazier, L. M., Alqahtani, S., Sulkowski, M. S., Vainorius, M., Akushevich, L., Fried, M. W. & Zeuzem, S. Oct 1 2017 In : Gut. 66, 10, p. 1844-1852 9 p.

Research output: Contribution to journalArticle

Ribavirin
Genotype
Safety
Infection
Fibrosis